AIM2: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid
NCT04463719 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107
Last updated 2025-11-10
Summary
There is an epidemic of thyroid cancer that is harmful to patients and the medical system. The study hypothesizes that the use of an electronic conversation aid during clinical visits can help patients and clinicians collaborate. The study aims to update a conversation aid prototype that was developed to support shared decision making in the diagnosis of thyroid cancer and conduct a pilot clinical trial to evaluate the feasibility of conducting a larger efficacy study.
Conditions
- Thyroid Nodules
- Thyroid Cancer
Interventions
- BEHAVIORAL
-
Counseling using the electronic conversation aid
Patients receive counseling about thyroid biopsy with the use of the conversation aid.
- BEHAVIORAL
-
counseling by routine care
Patients receive counseling by routine care without the use of the conversation aid
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Florida
lead OTHER
Principal Investigators
-
Naykky Singh Ospina · University of Florida
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-20
- Primary Completion
- 2024-09-30
- Completion
- 2024-09-30
Countries
- United States
Study Locations
More Related Trials
-
Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer
NCT01083550 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Mapping Patient Decision-making in Thyroid Cancer
NCT06411834 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
NCT00085293 ·Status: COMPLETED ·Phase: PHASE2
-
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
NCT02393690 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
NCT05733013 ·Status: RECRUITING
-
Improved Preoperative Selection of Cold Thyroid Nodules
NCT00297297 ·Status: UNKNOWN
-
Human-AI Collaboration for Ultrasound Diagnosis of Thyroid Nodules - a Clinical Trial
NCT06306599 ·Status: COMPLETED ·Phase: NA
-
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
NCT06073223 ·Status: COMPLETED ·Phase: NA
-
Radioiodine Planar and a SPECT/CT Imaging With Iodine-123 for Evaluation of Follicular Thyroid Nodules Prior to Surgery
NCT05591092 ·Status: COMPLETED
-
Three-dimensional Thyroid Education Model
NCT06146998 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Studies on Tumors of the Thyroid
NCT00001160 ·Status: RECRUITING
-
Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients
NCT03757637 ·Status: RECRUITING ·Phase: NA
-
Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine
NCT02773667 ·Status: COMPLETED
-
Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences
NCT05819593 ·Status: NOT_YET_RECRUITING
-
Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123
NCT02278198 ·Status: COMPLETED ·Phase: PHASE1
-
Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules
NCT01401855 ·Status: COMPLETED
-
Thalidomide in Treating Patients With Thyroid Cancer
NCT00026533 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
NCT05229341 ·Status: RECRUITING ·Phase: NA
-
Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition
NCT04619316 ·Status: UNKNOWN ·Phase: PHASE2
-
The Evaluation of the Diagnostic Properties of Intra-operative In-situ Thyroglobin Levels of Cervical Lymph Nodes, in the Discrimination Between Benign and Malignant Lymph Nodes in Thyroid Cancer: a Prospective Multicentre Study.
NCT02602717 ·Status: UNKNOWN ·Phase: NA
-
Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.
NCT06134830 ·Status: NOT_YET_RECRUITING
-
The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer
NCT00794053 ·Status: COMPLETED ·Phase: PHASE3
-
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
NCT03624751 ·Status: ACTIVE_NOT_RECRUITING
-
COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer
NCT06790589 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer
NCT00251316 ·Status: COMPLETED ·Phase: PHASE2